This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Tβ4 significantly suppressed the activation of the NLRP3 inflammasome and related inflammatory markers.
Why it matters
This research highlights a potential therapeutic role for Tβ4 in managing liver inflammation and fibrosis, which are common issues in various liver diseases.
How the study worked
The study used RAW 264.7 and LX-2 cells, priming them with LPS and stimulating with ATP to activate the NLRP3 inflammasome, while assessing the effects of Tβ4.
What this study cannot tell us
The study was conducted in vitro, so results may not directly translate to human conditions.
Read the original research
Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.
International journal of molecular sciences, 24(4)
Citation
Choi, Jihye; Cho, Yunsang; Choi, Hwal; Lee, Sangmin; Han, Hyeju; Lee, Jeonghyeon; Kwon, Jungkee. (2023). Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.. International journal of molecular sciences, 24(4). https://doi.org/10.3390/ijms24043439